Environment & Market Dynamics Analyses & Assessments

Payers Institutions- Governmental Healthcare Agencies – International NGOs

You would like to have a detailed strategic analysis of the market environment and its dynamics. Which future evolution to anticipate ?
You wish to see make your health policy or procurement practice evolve to sustain a specific healthcare expense or treatment access goal ?
  • Modelling of different scenarios: potential impact of new policy choice
You would like to evaluate the potential impact of a modification of the International Reference Pricing regulations by the Health Ministery ?
In the frame of a limited budget, how to prioritize the investments, budget allocations or financial supports to optimize the Return on Investment and Public Health impact?
  • Optimization-Rationalization of use of resources in a constraint environment
  • Support to elaboration of strategies (return on investment maximization, procurement optimization, etc…)

Examples of Ad Hoc analysis

Challenge

  • Client with portfolio of implantable medical devices needed a better understanding of the market and key players in multiple countries
  • Limited knowledge on the key players and their size, the reimbursement landscape of the underlying surgery and bundling within each segment
  • No clarity on current net price levels and pricing strategy for portfolio assets Need for portfolio pricing strategy

Approach & Solutions

  • Client with portfolio of implantable medical devices needed a better understanding of the market and key players in multiple countries
  • Limited knowledge on the key players and their size, the reimbursement landscape of the underlying surgery and bundling within each segment
  • No clarity on current net price levels and pricing strategy for portfolio assets Need for portfolio pricing strategy

Outcomes

  • Client with portfolio of implantable medical devices needed a better understanding of the market and key players in multiple countries
  • Limited knowledge on the key players and their size, the reimbursement landscape of the underlying surgery and bundling within each segment
  • No clarity on current net price levels and pricing strategy for portfolio assets Need for portfolio pricing strategy

grand titre

colonne 1 sous titre

zearaerearefdf

colonne 2 sous titre

afaefzegzefzef

colonne 3 sous titre

hyiyorutkurrtu

Outcomes

lkqjdglkj mlkdfjg